期刊文献+

半乳糖凝集素3对心力衰竭诊断价值的Meta分析 被引量:3

Diagnostic value of galectin 3 to heart failure: a Meta-analysis
下载PDF
导出
摘要 目的采用Meta分析评估半乳糖凝集素3对心力衰竭(心衰)的诊断价值。方法检索PubMed、EMbase、万方数据库和中国知网自数据库建库开始至2018年11月30日之前收录的关于半乳糖凝集素3对心力衰竭(心衰)诊断效能的中英文文献并提取数据,使用诊断准确性研究的质量评价工具-2(QUADAS-2)对纳入文献进行质量评估,采用MetaDiSc1.4软件全面分析半乳糖凝集素3诊断心力衰竭的价值。结果共纳入文献14篇,纳入研究存在非阈值效应引起的异质性,采用随机效应模型合并结果,合并灵敏度为0.78(95%CI:0.76~0.80);合并特异度为0.65(95%CI:0.63~0.68);合并阳性似然比为2.85(95%CI:2.07~3.92);合并阴性似然比0.28(95%CI:0.21~0.39);合并诊断比值比(DOR)为12.48(95%CI:6.48~24.06);ROC曲线下面积(AUC)为0.8531。结论半乳糖凝集素3对心衰有中等偏高程度的诊断价值,但仍需要设计合理的大样本研究来证明。 Objective To review the diagnostic value of galectin-3(Gal-3)to heart failure(HF)by applying Meta-analysis.Methods The databases of PubMed,EMbase,WanFang Data and CNKI were retrieved for searching the Chinese and English documents about the diagnostic efficacy of Gal-3 to HF from database establishing time to Nov.30,2018,and data was extracted.The quality of included documents was reviewed by using quality assessment of diagnostic accuracy studies-2(QUADAS-2)for study the diagnostic accuracy.The diagnostic value of Gal-3 to HF was comprehensively analyzed by using MetaDiSc1.4 software.Results There were totally 14 documents included,which had the heterogeneity caused by non-threshold effect.A randomized effect model was used to combine results of diagnostic value of Gal-3 to HF,and the results showed that the combined sensitivity was 0.78(95%CI:0.76~0.80),combined specificity was 0.65(95%CI:0.63~0.68),combined positive likelihood ratio was 2.85(95%CI:2.07~3.92),combined negative likelihood ratio was 0.28(95%CI:0.21~0.39),combined diagnostic odds ratio(DOR)was 12.48(95%CI:6.48-24.06),and AUC under ROC was 0.8531.Conclusion Gal-3 has approximately higher diagnostic value to HF,while the conclusion is needed to be certified by the study with large sample and reasonable design.
作者 张记收 王梦龙 刘剑芳 叶晶 王震 徐瑶 姜慧敏 叶迪 万军 Zhang Jishou;Wang Menglong;LiuJianfang;Ye Jing;Wang Zhen;Xu Yao;Jiang Huimin;Ye Di;Wan Jun(Department of Cardiology,People's Hospital,Cardiovascular Disease Institute,Hubei Provincial Key Laboratory of Cardiovascular Disease,Wuhan University,Wuhan 430060,China)
出处 《中国循证心血管医学杂志》 2020年第1期14-17,23,共5页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 半乳糖凝集素3 心力衰竭 META分析 Galectin-3 Heart failure Meta-analysis
  • 相关文献

参考文献6

二级参考文献59

  • 1Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused up- date incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Re- port of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide- lines Developed in Collaboration With the International Soci- ety for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-e90.
  • 2Nakahara S, Oka N, Wang Y, et al. Characterization of the nuclear import pathways of Galectin-3. Cancer Res 2006; 66: 9995-10006.
  • 3van Kimmenade RR, Januzzi JL Jr., Ellinor PT, et al. Utilityof amino-terminal pro-brain natriuretic peptide, Galectin-3, and apelin for the evaluation of patients with acute heart fail- ure. JAm Coll Cardio12006; 48: 1217-1224.
  • 4Lok D J, Van Der Meer P, de la Porte PW, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin ResCardio12010; 99: 323-328.
  • 5Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res 2008; 58:88-111.
  • 6Ueland T, Aukmst P, Broch K, et al. Galectin-3 in heart fail- ure: high levels are associated with all cause mortality, lnt J Cardio12011; 150:361 364.
  • 7van der Velde AR, Gullestad L, Ueland T, et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure data from CORONA and COACH. Circ" Heart Fail 2013; 6: 219326.
  • 8Milting H, Ellinghaus P, Seewald M, et al. Plasma biomarkers of mycordial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant 2008; 27:589 596.
  • 9Grandin EW, Jarolim P, Murphy SA, et al. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. Clin Chem 2012; 58: 267-273.
  • 10de Boer RA, Verweij N, van Veldhuisen D J, et al. A ge- home-wide association study of circulating galectin-3. PLoS ONE 2012; 7: e47385.

共引文献102

同被引文献13

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部